GC4711

· Galera Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GC4711, covering 2024-04-03 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer [Phase 2]